Brazil and Nigeria are emerging as key export destinations for Indian pharmaceutical firms amid global economic uncertainties, according to the commerce ministry data.
Nigeria emerged as one of the fastest growing destinations, adding USD 179 million in exports and contributing over 14 per cent to the total export growth during the first eight months of this fiscal year.
During April-November FY26, Brazil also recorded an increase of nearly USD 100 million exports, the data showed.
“These markets reflect rising healthcare access, expanding public procurement, and growing reliance on Indian generics, reinforcing India’s role as a preferred supplier to high growth demand intensive regions,” an official said.
The country’s pharmaceutical exports rose by 6.5 per cent to USD 20.48 billion during April-November 2025-26.
The data also showed that the US continues to be the single largest destination, accounting for over 31 per cent of exports in April-November 2025, while the overall gro​Brazil and Nigeria are emerging as key export destinations for Indian pharmaceutical firms amid global economic uncertainties, according to the commerce ministry data.
Nigeria emerged as one of the fastest growing destinations, adding USD 179 million in exports and contributing over 14 per cent to the total export growth during the first eight months of this fiscal year.
During April-November FY26, Brazil also recorded an increase of nearly USD 100 million exports, the data showed.
“These markets reflect rising healthcare access, expanding public procurement, and growing reliance on Indian generics, reinforcing India’s role as a preferred supplier to high growth demand intensive regions,” an official said.
The country’s pharmaceutical exports rose by 6.5 per cent to USD 20.48 billion during April-November 2025-26.
The data also showed that the US continues to be the single largest destination, accounting for over 31 per cent of exports in April-November 2025, while the overall gro ​Latest News [ SOBAN NEWS: International and National ]
